Mobile

An open-label study of two single oral doses of galantamine, examining the pharmacokinetics, safety, and tolerability in children with Down syndrome

Update Il y a 4 ans
Reference: EUCTR2006-003359-19

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To determine the pharmacokinetic characteristics of glantamine after 2 single oral doses in children with Down syndrome.

Inclusion criteria

  • Children with Down syndrom

Links